White Pine Capital’s CVS Health CVS Stock Holding History

White Pine Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,787	Closed	-$221K	–	229
2025 Q4	$221K	Hold	2,787	–	–	0.06%	213
2025 Q3	$210K	Buy	+2,787	New	+$191K	0.06%	220
2025 Q2	–	Sell	-3,187	Closed	-$216K	–	224
2025 Q1	$216K	Buy	+3,187	New	+$191K	0.07%	209
2024 Q4	–	Sell	-5,187	Closed	-$326K	–	221
2024 Q3	$326K	Sell	5,187 -4,494	-46%	-$262K	0.11%	183
2024 Q2	$572K	Sell	9,681 -25	-0.3%	-$1.56K	0.22%	121
2024 Q1	$657K	Sell	9,706 -209	-2%	-$16K	0.25%	113
2023 Q4	$783K	Sell	9,915 -1,067	-10%	-$75.9K	0.3%	100
2023 Q3	$767K	Sell	10,982 -1,056	-9%	-$74.8K	0.31%	101
2023 Q2	$832K	Buy	12,038 +169	+1%	+$12K	0.31%	99
2023 Q1	$882K	Sell	11,869 -439	-4%	-$36.8K	0.34%	92
2022 Q4	$1.15M	Buy	12,308 +100	+0.8%	+$9.65K	0.45%	77
2022 Q3	$1.16M	Buy	12,208 +25	+0.2%	+$2.48K	0.48%	72
2022 Q2	$1.13M	Sell	12,183 -678	-5%	-$66.2K	0.44%	77
2022 Q1	$1.3M	Buy	12,861 +130	+1%	+$13.7K	0.4%	80
2021 Q4	$1.31M	Hold	12,731	–	–	0.39%	87
2021 Q3	$1.08M	Hold	12,731	–	–	0.33%	95
2021 Q2	$1.05M	Buy	12,731 +275	+2%	+$22.5K	0.31%	101
2021 Q1	$937K	Sell	12,456 -175	-1%	-$12.7K	0.3%	109
2020 Q4	$863K	Buy	12,631 +478	+4%	+$31.1K	0.31%	105
2020 Q3	$710K	Hold	12,153	–	–	0.29%	100
2020 Q2	$790K	Buy	12,153 +165	+1%	+$10.4K	0.33%	89
2020 Q1	$711K	Buy	11,988 +150	+1%	+$10K	0.36%	81
2019 Q4	$879K	Sell	11,838 -2	-0%	-$140	0.34%	85
2019 Q3	$747K	Sell	11,840 -125	-1%	-$7.41K	0.28%	109
2019 Q2	$652K	Hold	11,965	–	–	0.24%	122
2019 Q1	$645K	Sell	11,965 -25	-0.2%	-$1.54K	0.24%	129
2018 Q4	$786K	Buy	11,990 +104	+0.9%	+$7.76K	0.32%	95
2018 Q3	$936K	Hold	11,886	–	–	0.33%	97
2018 Q2	$765K	Sell	11,886 -975	-8%	-$64.3K	0.27%	116
2018 Q1	$800K	Hold	12,861	–	–	0.29%	105
2017 Q4	$932K	Hold	12,861	–	–	0.34%	91
2017 Q3	$1.05K	Sell	12,861 -175	-1%	-$13.8K	﹤0.01%	82
2017 Q2	$1.05M	Sell	13,036 -235	-2%	-$18.6K	0.41%	64
2017 Q1	$1.04M	Sell	13,271 -5,465	-29%	-$436K	0.42%	65
2016 Q4	$1.48M	Sell	18,736 -300	-2%	-$24.3K	0.63%	41
2016 Q3	$1.69M	Sell	19,036 -180	-0.9%	-$17K	0.72%	36
2016 Q2	$1.84M	Sell	19,216 -302	-2%	-$30.1K	0.77%	32
2016 Q1	$2.02M	Sell	19,518 -167	-0.8%	-$16.2K	0.87%	26
2015 Q4	$1.93M	Sell	19,685 -8,839	-31%	-$866K	0.85%	28
2015 Q3	$2.75M	Sell	28,524 -323	-1%	-$34K	1.28%	10
2015 Q2	$3.02M	Sell	28,847 -5,554	-16%	-$567K	1.3%	11
2015 Q1	$3.55M	Sell	34,401 -6,175	-15%	-$625K	1.44%	7
2014 Q4	$3.91M	Sell	40,576 -1,150	-3%	-$101K	1.32%	8
2014 Q3	$3.32M	Hold	41,726	–	–	1.13%	16
2014 Q2	$3.15M	Sell	41,726 -1,950	-4%	-$147K	1.09%	16
2014 Q1	$3.27M	Buy	43,676 +2,295	+6%	+$162K	1.12%	17
2013 Q4	$2.96M	Sell	41,381 -30,179	-42%	-$1.94M	1.04%	22
2013 Q3	$4.06M	Sell	71,560 -8,950	-11%	-$533K	1.4%	9
2013 Q2	$4.6M	Buy	+80,510	New	+$4.66M	1.6%	7

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

White Pine Capital's CVS Position: Q1 2026 in Review

White Pine Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,787 shares — an estimated $221K sold.

White Pine Capital first reported a position in CVS in Q2 2013 and held it in 49 quarters. The position peaked at $4.6M in Q2 2013. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

White Pine Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
White Pine Capital sold 2,787 CVS Health shares in Q1 2026, an estimated $221K.
White Pine Capital first reported a position in CVS Health in Q2 2013 and held it in 49 quarters.
White Pine Capital's CVS Health position peaked at $4.6M in Q2 2013.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.